Respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which prevents infection by respiratory syncytial virus. The global RSV Vaccine market size is expected to reach US$ 261 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. One of the major benefits of referring RSV Vaccine Market research is it […]
